The pet arthritis market is showing significant growth due to the increased quest by pet owners to improve the quality of life for their pets. With increased life expectancy for pets and growing concern for animal comfort and health, this market is set to increase rapidly from an estimated USD 3.53 billion in 2024 to USD 8.15 billion in 2035, with a CAGR of 7.9%. The growing adoption of pets, especially dogs and cats, coupled with comfort and health consciousness, is leading to increased demand for innovative arthritis treatments and management solutions.

What is Pet Arthritis?

Arthritis is a very common ailment in pets, especially among older animals. The condition involves inflammation and pains in the joints, which grossly impairs mobility and general comfort. While more common in dogs, especially large breeds, it does occur in cats and other animals as well. Management of arthritis in pets embraces a variety of products such as pharmaceuticals, dietary supplements, therapeutic devices, and alternative treatments aimed at alleviating joint pain and improving mobility.

Market Dynamics Driving Growth

The Shift Towards Holistic and Natural Treatments

Some major trends that will drive growth in the pet arthritis market include the rising demand for natural and alternative therapies. With increased awareness of possible adverse side effects from conventional medications, such as NSAIDs, many pet owners have started exploring holistic options. This includes herbal supplements, acupuncture, laser therapy, and other non-invasive treatments. Indeed, a study conducted by APPA found that 45% of owners prefer to use natural products when taking their pets' health into consideration. The NASC also reported that products addressing joint health, such as those containing glucosamine and omega-3 fatty acids, are among the fastest-growing supplements.

Accessibility and Affordability Challenges

Despite the increase in the availability of various forms of treatments for arthritis, the cost remains incredibly high and unaffordable for many owners of pets. Advanced treatments, including surgery and medication over a long period of time, are very expensive. Indeed, the APPA reports that as many as 40% of owners consider cost to be a major factor in deciding whether to pursue veterinary care. Moreover, since few pets have any insurance covering chronic conditions, such as arthritis, many owners cannot afford effective treatment.

To address this, the market is seeing an influx of more affordable and accessible treatments, with companies offering a range of products from budget-friendly supplements to more innovative therapies that reduce the need for expensive, invasive procedures.

Non-Invasive Innovations in Treatment

Advancements in veterinary medicine are making it easier to manage pet arthritis with minimal discomfort. Non-invasive treatments like laser therapy, hydrotherapy, and regenerative medicine (such as platelet-rich plasma (PRP) therapy and stem cell therapy) are gaining traction. These treatments not only help manage pain but also promote healing, allowing pets to recover faster with fewer side effects.

Telemedicine in veterinary care is also gaining its momentum, allowing pet owners to consult specialists remotely. This is particularly helpful for owners in rural areas who may not normally have easy access to specialized veterinary services. The integration of new technology, in conjunction with traditional treatments, allows the pet arthritis market to offer more personalized, convenient, and effective care options for pets.

Key Products in the Market

The pet arthritis market is diverse, offering a wide range of products to address joint pain and improve mobility. These include:

Medications: NSAIDs, corticosteroids, and other pain relievers.

Assistive Devices: Joint braces, mobility aids, and other products designed to support pets' movement.

Alternative Therapies: Acupuncture, laser therapy, among other holistic therapies.

Nutritional Supplements: Products like glucosamine, omega-3 fatty acids, and other joint health supplements.

Each product type serves a unique need, whether it's easing pain, improving joint function, or helping prevent further degeneration.

Regional Insights

North America

North America, with higher rates of pet ownership, increasing awareness about pet health, and greater demand for effective arthritis treatments, remains the largest market for pet arthritis. Countries like the U.S. and Canada are more actively researching and developing advanced treatment options, where both veterinary practices and manufacturers are considered. Increasingly, natural and holistic approaches are in demand from pet owners in this region-a fact reflective of the broader trend toward pet humanization.

Asia Pacific

The fast growth of the Asia Pacific market is promoted by rapid urbanization, increasing the rate of pet ownership, and growing concern for the health status of pets. While demand for pet care and new types of treatments is increasing, the market is seeing very fast growth in countries such as China, Japan, and India. Regulatory challenges, however, along with social diversity across the region, mean that specific countries require specific strategies in order to address their unique needs.

The Competitive Landscape

The pet arthritis market is highly competitive, with several key players dominating the space. Major companies include Zoetis Inc., Boehringer Ingelheim, Elanco Animal Health, and Merial (Boehringer Ingelheim), all of which offer a range of products designed to manage arthritis in pets. These companies are continuously innovating, with new treatments and technologies emerging regularly.

For instance, in 2023, the U.S. FDA approved Zoetis's Librela™ (bedinvetmab injection) for the control of osteoarthritis pain in dogs. Still, on biologicals, UCB's BIMZELX® (bimekizumab-bkzx) received FDA approval for treating psoriatic arthritis in humans-a reflection of growing interest in such biological therapies in the animal health space.

Final Thoughts: A Bright Future for Pet Arthritis Care

As pets continue to become integral parts of families, the demand for high-quality care will only grow. Pet arthritis is a common condition that affects millions of animals worldwide, but thanks to innovations in veterinary medicine, owners now have a broader range of effective treatment options at their disposal. Whether through traditional medications, non-invasive therapies, or natural supplements, the future of pet arthritis care looks promising, offering new hope for pets living with this painful condition.

If you are a pet owner who is concerned with your furry friend's mobility or pain, it's important to talk to your veterinarian about the best options for managing arthritis. The pet arthritis market is rapidly developing, and with a wider range of treatments than ever, there has never been a better time to explore options that can help improve your pet's quality of life.

To explore in-depth analysis in this report - Request Free Sample Report